R. Lévy Et Al. , "Human CARMIL2 deficiency underlies a broader immunological and clinical phenotype than CD28 deficiency.," The Journal of experimental medicine , vol.220, no.2, 2023
Lévy, R. Et Al. 2023. Human CARMIL2 deficiency underlies a broader immunological and clinical phenotype than CD28 deficiency.. The Journal of experimental medicine , vol.220, no.2 .
Lévy, R., Gothe, F., Momenilandi, M., Magg, T., Materna, M., Peters, P., ... Raedler, J.(2023). Human CARMIL2 deficiency underlies a broader immunological and clinical phenotype than CD28 deficiency.. The Journal of experimental medicine , vol.220, no.2.
Lévy, Romain Et Al. "Human CARMIL2 deficiency underlies a broader immunological and clinical phenotype than CD28 deficiency.," The Journal of experimental medicine , vol.220, no.2, 2023
Lévy, Romain Et Al. "Human CARMIL2 deficiency underlies a broader immunological and clinical phenotype than CD28 deficiency.." The Journal of experimental medicine , vol.220, no.2, 2023
Lévy, R. Et Al. (2023) . "Human CARMIL2 deficiency underlies a broader immunological and clinical phenotype than CD28 deficiency.." The Journal of experimental medicine , vol.220, no.2.
@article{article, author={Romain Lévy Et Al. }, title={Human CARMIL2 deficiency underlies a broader immunological and clinical phenotype than CD28 deficiency.}, journal={The Journal of experimental medicine}, year=2023}